Pulmonary Fibrosis Wiki resources & Pulmonary Fibrosis information at HealthHaven.com
advertise
toolbar
services
publishers
database
membership
Dr. Paul

Search  for    ?
web dir image video media news gallery wiki shop 
about
HealthBot
stats
live show
health store
shirts
JOIN/LOGIN
Pulmonary fibrosis:
Interstitial lung disease
Classification and external resources
End-stage pulmonary fibrosis of unknown origin, taken from an autopsy in the 1980s.
ICD-10 J84.9
ICD-9 506.4, 508.1, 515, 516.3, 714.81, 770.7
DiseasesDB 31509
eMedicine ped/1950 
MeSH D017563

Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD),[1] refers to a group of lung diseases affecting the interstitium of the lung:[2] alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. The term ILD is used to distinguish these diseases from obstructive airways diseases.

Most types of ILD involve fibrosis, but this is not essential; indeed fibrosis is often a later feature. The phrase "pulmonary fibrosis" is no longer considered a synonym, but the term is still used to denote ILD involving fibrosis.[3] The term is commonly combined with idiopathic in "idiopathic pulmonary fibrosis",[4][5][6] denoting fibrotic ILD that cannot be ascribed to a distinct primary cause.

Contents

[edit] Causes

The alveoli
Micrograph of usual interstitial pneumonia (UIP). UIP is the most common pattern of idiopathic interstitial pneumonia (a type of interstitial lung disease) and usually represents idiopathic pulmonary fibrosis. H&E stain. Autopsy specimen.

ILD may be classified according to the cause.[7] One method of classification is as follows

  1. Inhaled substances
  2. Drug induced
  3. Connective tissue disease
  4. Infection
  5. Idiopathic
  6. Malignancy

[edit] Investigation

Patients with pneumocystis pneumonia can present with interstitial lung disease, as seen in the reticular markings on this AP chest x-ray

Investigation is tailored towards the symptoms and signs. Most patients have blood testing, chest x-ray, pulmonary function testing, and high resolution CT thorax.

A lung biopsy is required if the clinical history and imaging is not clearly suggestive of a specific diagnosis or malignancy cannot otherwise be ruled-out.

[edit] Treatment

ILD is not a single disease, but encompasses many different pathological processes. Hence treatment is different for each disease.

If a specific occupational exposure cause is found, the person should avoid that environment. If a drug cause is suspected, that drug should be discontinued.

Many idiopathic and connective tissue-based causes of ILD are treated with corticosteroids,[8] such as prednisolone. Some patients respond to immunosuppressant treatment. Patients with hypoxemia may be given supplemental oxygen.

[edit] References

[edit] External links


Product Results:

A number of studies have demonstrated that increased free radical activity plays an important role in all cases of high blood pressure, because increased free radicals cause cellular damage and inactivate nitric oxide. Nitric oxide, an important molecular regulator of blood pressure, helps control blood pressure by dilating blood vessels. Antioxidants, powerful free radical scavengers, may help restore activities of nitric oxide and help to control blood pressure. This is the main theoretical basis of HypertrilTM. In addition to antioxidant activities, Hypertril also provides essential nutrients to support blood pressure control and improve circulation. :In a study performed at the Institut de Cardiologie de Montreal, Canada, Hypertril demonstrated a significant reduction in MAP (Mean Arterial Pressure) and ventricular function. Amazingly, right ventricular weight/body weight ratio was also decreased. Hypertril treatment also significantly improved LVSP (Left Ventricular Systolic Pressure) and left ventricular relaxation as assessed by left ventricular end diastolic pressure (LVEDP) was also significantly reduced by Hypertril treatment. Hypertril reduction of LVEDP was associated with a decrease in lung weight/body weight ratio. Consistent with this latter result, right ventricular hypertrophy was also reduced with Hypertril therapy. Thus, Hypertril may be beneficial in the treatment of pulmonary hypertension via its therapeutic action on LVEDP.
Hypertril for Pulmonary Hypertension -...
Case of 6 Amount in package - Case
Novasource Pulmonary 1000 Ml Case of 6
Size is 20" W by 26" H
Chronic Obstructive Pulmonary Disease (COPD)...
Edition: Fifth ISBN-10: 0-7817-7611-2
Cardiovascular + Pulmonary Words- 5th...
Defines COPD along with causes, symptoms, diagnosis and treatments. Shows respiratory anatomy and illustrates two disorders associated with COPD: Emphysema and Chronic Bronchitis.
Chronic Obstructive Pulmonary Disease (COPD)...

Search  for    ?
web dir image video media news gallery wiki shop 


↑ top of page ↑